{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,24]],"date-time":"2026-06-24T18:52:21Z","timestamp":1782327141709,"version":"3.54.5"},"reference-count":41,"publisher":"Elsevier BV","issue":"14","license":[{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,7,10]],"date-time":"2024-07-10T00:00:00Z","timestamp":1720569600000},"content-version":"vor","delay-in-days":9,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100012246","name":"Priority Academic Program Development of Jiangsu Higher Education Institutions","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100012246","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["32071307"],"award-info":[{"award-number":["32071307"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Heliyon"],"published-print":{"date-parts":[[2024,7]]},"DOI":"10.1016\/j.heliyon.2024.e34494","type":"journal-article","created":{"date-parts":[[2024,7,11]],"date-time":"2024-07-11T06:08:58Z","timestamp":1720678138000},"page":"e34494","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["Repurposing anti-osteoporosis drugs for autoimmune diseases: A two-sample Mendelian randomization study"],"prefix":"10.1016","volume":"10","author":[{"given":"Pan","family":"Xiang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chengyuan","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruoyi","family":"Shen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoxiong","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuerong","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qi","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zongping","family":"Luo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0000-3316-3218","authenticated-orcid":false,"given":"Qin","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.heliyon.2024.e34494_bib1","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1007\/s00125-003-1045-4","article-title":"Temporal changes in the frequencies of HLA genotypes in patients with Type 1 diabetes--indication of an increased environmental pressure?","volume":"46","author":"Hermann","year":"2003","journal-title":"Diabetologia"},{"issue":"9","key":"10.1016\/j.heliyon.2024.e34494_bib2","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.1038\/ng.3379","article-title":"Widespread non-additive and interaction effects within HLA loci modulate the risk of autoimmune diseases","volume":"47","author":"Lenz","year":"2015","journal-title":"Nat. Genet."},{"issue":"5","key":"10.1016\/j.heliyon.2024.e34494_bib3","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1093\/aje\/kwv292","article-title":"Prediction and prevention of autoimmune disease in the 21st century: a review and preview","volume":"183","author":"Rose","year":"2016","journal-title":"American journal of epidemiology"},{"issue":"10335","key":"10.1016\/j.heliyon.2024.e34494_bib4","doi-asserted-by":"crossref","first-page":"1646","DOI":"10.1016\/S0140-6736(22)00461-5","article-title":"Acute glomerulonephritis","volume":"399","author":"Sethi","year":"2022","journal-title":"Lancet (London, England)"},{"issue":"4","key":"10.1016\/j.heliyon.2024.e34494_bib5","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1111\/joim.12395","article-title":"Human autoimmune diseases: a comprehensive update","volume":"278","author":"Wang","year":"2015","journal-title":"J. Intern. Med."},{"issue":"2","key":"10.1016\/j.heliyon.2024.e34494_bib6","doi-asserted-by":"crossref","DOI":"10.1016\/j.autrev.2020.102743","article-title":"An updated advance of autoantibodies in autoimmune diseases","volume":"20","author":"Xiao","year":"2021","journal-title":"Autoimmun. Rev."},{"issue":"12","key":"10.1016\/j.heliyon.2024.e34494_bib7","doi-asserted-by":"crossref","DOI":"10.1016\/j.autrev.2022.103210","article-title":"Mendelian randomization as a tool to gain insights into the mosaic causes of autoimmune diseases","volume":"21","author":"Chen","year":"2022","journal-title":"Autoimmun. Rev."},{"issue":"5","key":"10.1016\/j.heliyon.2024.e34494_bib8","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijantimicag.2022.106587","article-title":"Reducing the off-target endocrinologic adverse effects of azole antifungals-can it be done?","volume":"59","author":"Balcerek","year":"2022","journal-title":"Int. J. Antimicrob. Agents"},{"issue":"2","key":"10.1016\/j.heliyon.2024.e34494_bib9","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a039230","article-title":"Human genomics and drug development","volume":"12","author":"Schmidt","year":"2022","journal-title":"Cold Spring Harb Perspect Med"},{"issue":"2","key":"10.1016\/j.heliyon.2024.e34494_bib10","first-page":"213","article-title":"Osteoporosis","volume":"107","author":"Gopinath","year":"2023","journal-title":"Med. Clin."},{"issue":"5","key":"10.1016\/j.heliyon.2024.e34494_bib11","first-page":"873","article-title":"Osteoporosis in older adults","volume":"104","author":"Johnston","year":"2020","journal-title":"Med. Clin."},{"issue":"4","key":"10.1016\/j.heliyon.2024.e34494_bib12","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/S2213-8587(22)00012-2","article-title":"Osteoporosis in men","volume":"10","author":"Vilaca","year":"2022","journal-title":"Lancet Diabetes Endocrinol."},{"issue":"10169","key":"10.1016\/j.heliyon.2024.e34494_bib13","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1016\/S0140-6736(18)32112-3","article-title":"Osteoporosis","volume":"393","author":"Compston","year":"2019","journal-title":"Lancet (London, England)"},{"issue":"1","key":"10.1016\/j.heliyon.2024.e34494_bib14","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1007\/s00198-022-06570-0","article-title":"Sequential therapy with once-weekly teriparatide injection followed by alendronate versus monotherapy with alendronate alone in patients at high risk of osteoporotic fracture: final results of the Japanese Osteoporosis Intervention Trial-05","volume":"34","author":"Mori","year":"2023","journal-title":"Osteoporos. Int. : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA"},{"issue":"1","key":"10.1016\/j.heliyon.2024.e34494_bib15","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1080\/10717544.2022.2152135","article-title":"Risedronate-loaded aerogel scaffolds for bone regeneration","volume":"30","author":"El-Wakil","year":"2023","journal-title":"Drug Deliv."},{"issue":"1","key":"10.1016\/j.heliyon.2024.e34494_bib16","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1007\/s11657-023-01227-9","article-title":"Zoledronic acid and denosumab for periprosthetic bone mineral density loss after joint arthroplasty: a systematic review and meta-analysis of randomized controlled trials","volume":"18","author":"Li","year":"2023","journal-title":"Arch. Osteoporosis"},{"key":"10.1016\/j.heliyon.2024.e34494_bib17","doi-asserted-by":"crossref","DOI":"10.1016\/j.bone.2022.116480","article-title":"Verification of efficacy and safety of ibandronate or denosumab for postmenopausal osteoporosis after 12-month treatment with romosozumab as sequential therapy: the prospective VICTOR study","volume":"162","author":"Kobayakawa","year":"2022","journal-title":"Bone"},{"key":"10.1016\/j.heliyon.2024.e34494_bib18","doi-asserted-by":"crossref","DOI":"10.1016\/j.bone.2020.115222","article-title":"History of etidronate","volume":"134","author":"Watts","year":"2020","journal-title":"Bone"},{"key":"10.1016\/j.heliyon.2024.e34494_bib19","doi-asserted-by":"crossref","DOI":"10.1016\/j.bone.2019.115081","article-title":"Clinical effectiveness of denosumab, raloxifene, romosozumab, and teriparatide for the prevention of osteoporotic fragility fractures: a systematic review and network meta-analysis","volume":"130","author":"Simpson","year":"2020","journal-title":"Bone"},{"issue":"2","key":"10.1016\/j.heliyon.2024.e34494_bib20","doi-asserted-by":"crossref","first-page":"182","DOI":"10.7326\/M22-0684","article-title":"Effectiveness and safety of treatments to prevent fractures in people with low bone mass or primary osteoporosis: a living systematic review and network meta-analysis for the American college of physicians","volume":"176","author":"Ayers","year":"2023","journal-title":"Ann. Intern. Med."},{"issue":"10329","key":"10.1016\/j.heliyon.2024.e34494_bib21","doi-asserted-by":"crossref","first-page":"1080","DOI":"10.1016\/S0140-6736(21)02646-5","article-title":"Drug therapy for osteoporosis in older adults","volume":"399","author":"Reid","year":"2022","journal-title":"Lancet (London, England)"},{"issue":"1","key":"10.1016\/j.heliyon.2024.e34494_bib22","doi-asserted-by":"crossref","first-page":"4101","DOI":"10.1038\/s41467-023-39586-z","article-title":"Macrophage-to-endothelial cell crosstalk by the cholesterol metabolite 27HC promotes atherosclerosis in male mice","volume":"14","author":"Yu","year":"2023","journal-title":"Nat. Commun."},{"key":"10.1016\/j.heliyon.2024.e34494_bib23","article-title":"The immune activity of selective estrogen receptor modulators is gene and macrophage subtype-specific yet converges on Il1b downregulation","volume":"165","author":"Sfogliarini","year":"2023","journal-title":"Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie"},{"key":"10.1016\/j.heliyon.2024.e34494_bib24","doi-asserted-by":"crossref","DOI":"10.3389\/fcell.2023.1158539","article-title":"Novel chimeric antigen receptor T cell-based immunotherapy: a perspective for triple-negative breast cancer","volume":"11","author":"Geng","year":"2023","journal-title":"Front. Cell Dev. Biol."},{"key":"10.1016\/j.heliyon.2024.e34494_bib25","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2023.1196269","article-title":"The causal relationship between autoimmune diseases and osteoporosis: a study based on Mendelian randomization","volume":"14","author":"Wu","year":"2023","journal-title":"Front. Endocrinol."},{"issue":"8","key":"10.1016\/j.heliyon.2024.e34494_bib26","doi-asserted-by":"crossref","first-page":"1334","DOI":"10.1002\/art.42502","article-title":"Association between rheumatoid arthritis and osteoporosis in Japanese populations: a mendelian randomization study","volume":"75","author":"Deng","year":"2023","journal-title":"Arthritis Rheumatol."},{"issue":"7","key":"10.1016\/j.heliyon.2024.e34494_bib27","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1007\/s10654-015-0011-z","article-title":"Using published data in Mendelian randomization: a blueprint for efficient identification of causal risk factors","volume":"30","author":"Burgess","year":"2015","journal-title":"Eur. J. Epidemiol."},{"issue":"7","key":"10.1016\/j.heliyon.2024.e34494_bib28","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1007\/s10654-023-01000-9","article-title":"Repurposing antidiabetic drugs for rheumatoid arthritis: results from a two-sample Mendelian randomization study","volume":"38","author":"Qin","year":"2023","journal-title":"Eur. J. Epidemiol."},{"issue":"1","key":"10.1016\/j.heliyon.2024.e34494_bib29","doi-asserted-by":"crossref","first-page":"1420","DOI":"10.1038\/s41467-024-45655-8","article-title":"PheWAS-based clustering of Mendelian Randomisation instruments reveals distinct mechanism-specific causal effects between obesity and educational attainment","volume":"15","author":"Darrous","year":"2024","journal-title":"Nat. Commun."},{"issue":"6","key":"10.1016\/j.heliyon.2024.e34494_bib30","doi-asserted-by":"crossref","first-page":"964","DOI":"10.1136\/ard.2009.126532","article-title":"EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs","volume":"69","author":"Smolen","year":"2010","journal-title":"Ann. Rheum. Dis."},{"issue":"8","key":"10.1016\/j.heliyon.2024.e34494_bib31","doi-asserted-by":"crossref","first-page":"2396","DOI":"10.1002\/jps.24058","article-title":"Characterization and evaluation of triamcinolone, raloxifene, and their dual-loaded microspheres as prospective local treatment system in rheumatic rat joints","volume":"103","author":"Ocal","year":"2014","journal-title":"J. Pharmaceut. Sci."},{"key":"10.1016\/j.heliyon.2024.e34494_bib32","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.mehy.2018.10.002","article-title":"The importance of inhibition of a catabolic pathway of methotrexate metabolism in its efficacy for rheumatoid arthritis","volume":"122","author":"Morgan","year":"2019","journal-title":"Med. Hypotheses"},{"key":"10.1016\/j.heliyon.2024.e34494_bib33","doi-asserted-by":"crossref","DOI":"10.1016\/j.compbiomed.2023.107206","article-title":"Estradiol is a key candidate for treating ankylosing spondylolisthesis with traditional Chinese medicine","volume":"164","author":"Zheng","year":"2023","journal-title":"Comput. Biol. Med."},{"key":"10.1016\/j.heliyon.2024.e34494_bib34","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1016\/j.micpath.2018.12.029","article-title":"Association of oestrogen receptor alpha gene polymorphisms with systemic lupus erythematosus risk: an updated meta-analysis","volume":"127","author":"Xie","year":"2019","journal-title":"Microb. Pathog."},{"issue":"10","key":"10.1016\/j.heliyon.2024.e34494_bib35","doi-asserted-by":"crossref","first-page":"1880","DOI":"10.1093\/rheumatology\/kew248","article-title":"Estrogen-induced expression of tumor necrosis factor-like weak inducer of apoptosis through ER\u03b1 accelerates the progression of lupus nephritis","volume":"55","author":"Xue","year":"2016","journal-title":"Rheumatology"},{"issue":"5","key":"10.1016\/j.heliyon.2024.e34494_bib36","doi-asserted-by":"crossref","DOI":"10.3390\/cells12050766","article-title":"Low gut microbial diversity augments estrogen-driven pulmonary fibrosis in female-predominant interstitial lung disease","volume":"12","author":"Chioma","year":"2023","journal-title":"Cells"},{"key":"10.1016\/j.heliyon.2024.e34494_bib37","article-title":"Complement factor B inhibitor LNP023 improves lupus nephritis in MRL\/lpr mice","volume":"153","author":"Chen","year":"2022","journal-title":"Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie"},{"issue":"1","key":"10.1016\/j.heliyon.2024.e34494_bib38","doi-asserted-by":"crossref","first-page":"9157","DOI":"10.1038\/s41598-022-13291-1","article-title":"Identification of candidate biomarkers and pathways associated with type 1 diabetes mellitus using bioinformatics analysis","volume":"12","author":"Pujar","year":"2022","journal-title":"Sci. Rep."},{"issue":"1","key":"10.1016\/j.heliyon.2024.e34494_bib39","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-023-50007-5","article-title":"Circulating ESR1, long non-coding RNA HOTAIR and microRNA-130a gene expression as biomarkers for breast cancer stage and metastasis","volume":"13","author":"Abdel-Hamid","year":"2023","journal-title":"Sci. Rep."},{"issue":"33","key":"10.1016\/j.heliyon.2024.e34494_bib40","doi-asserted-by":"crossref","first-page":"E7795","DOI":"10.1073\/pnas.1803468115","article-title":"Estrogen receptor-1 is a key regulator of HIV-1 latency that imparts gender-specific restrictions on the latent reservoir","volume":"115","author":"Das","year":"2018","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"2","key":"10.1016\/j.heliyon.2024.e34494_bib41","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.02337-2016","article-title":"Oestrogen inhibition reverses pulmonary arterial hypertension and associated metabolic defects","volume":"50","author":"Chen","year":"2017","journal-title":"Eur. Respir. J."}],"container-title":["Heliyon"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2405844024105257?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2405844024105257?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,18]],"date-time":"2026-03-18T13:57:17Z","timestamp":1773842237000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2405844024105257"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,7]]},"references-count":41,"journal-issue":{"issue":"14","published-print":{"date-parts":[[2024,7]]}},"alternative-id":["S2405844024105257"],"URL":"https:\/\/doi.org\/10.1016\/j.heliyon.2024.e34494","relation":{},"ISSN":["2405-8440"],"issn-type":[{"value":"2405-8440","type":"print"}],"subject":[],"published":{"date-parts":[[2024,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Repurposing anti-osteoporosis drugs for autoimmune diseases: A two-sample Mendelian randomization study","name":"articletitle","label":"Article Title"},{"value":"Heliyon","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.heliyon.2024.e34494","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"e34494"}}